KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Income from Continuing Operations (2016 - 2025)

Acadia Pharmaceuticals has reported Income from Continuing Operations over the past 16 years, most recently at 23244000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 23244000.0 for Q4 2025, down 83.83% from a year ago — trailing twelve months through Dec 2025 was 140683000.0 (down 37.89% YoY), and the annual figure for FY2025 was 140676000.0, down 37.88%.
  • Income from Continuing Operations for Q4 2025 was 23244000.0 at Acadia Pharmaceuticals, down from 71784000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ACAD hit a ceiling of 143751000.0 in Q4 2024 and a floor of 113056000.0 in Q1 2022.
  • Median Income from Continuing Operations over the past 5 years was 6678500.0 (2021), compared with a mean of 3903700.0.
  • Biggest five-year swings in Income from Continuing Operations: crashed 139.49% in 2023 and later skyrocketed 2935.36% in 2024.
  • Acadia Pharmaceuticals' Income from Continuing Operations stood at 43094000.0 in 2021, then increased by 3.28% to 41679000.0 in 2022, then skyrocketed by 209.68% to 45714000.0 in 2023, then skyrocketed by 214.46% to 143751000.0 in 2024, then plummeted by 83.83% to 23244000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 23244000.0 (Q4 2025), 71784000.0 (Q3 2025), and 26655000.0 (Q2 2025) per Business Quant data.